Bryan Dickinson
@chembiobryan.bsky.social
1.8K followers 330 following 86 posts
chemical/synthetic biologist, Luddite trying to find better ways to make molecules that do important stuff, dad, @uchicago professor of chemistry http://www.dickinsonlab.uchicago.edu/
Posts Media Videos Starter Packs
chembiobryan.bsky.social
Good balanced take on AI in protein design...hype and potential:

blog.genesmindsmachines.com/p/we-still-c...
They've done studies, you know.
60% of the time it works every time.
Reposted by Bryan Dickinson
uchichemistry.bsky.social
A Warm Welcome to Our Newest UChicago Chemists! As an incoming student, you're now at the epicenter of chemical innovation. We're excited to have you become part of our story and see the discoveries you will make this year.
Reposted by Bryan Dickinson
stephanhacker2.bsky.social
Excited to hear about the amazing research from the @chembiobryan.bsky.social group on taming acyl chlorides for #ChemBio applications from the first author of the @natchem.nature.com paper, @shubha-pani.bsky.social.

Register for free for the 5th Virtual #ChemBioTalks to join: cvent.me/G1geWW
chembiotalks.bsky.social
The third and final Flash Talk of the 5th Virtual #ChemBioTalks will be given by Shubhashree Pani (@shubha-pani.bsky.social) from the group of @chembiobryan.bsky.social: "Masked acylating agents for proximity labeling of biomolecules" www.nature.com/articles/s41...
#ChemBio #ChemSky #DrugDiscovery
Reposted by Bryan Dickinson
chembiotalks.bsky.social
The third and final Flash Talk of the 5th Virtual #ChemBioTalks will be given by Shubhashree Pani (@shubha-pani.bsky.social) from the group of @chembiobryan.bsky.social: "Masked acylating agents for proximity labeling of biomolecules" www.nature.com/articles/s41...
#ChemBio #ChemSky #DrugDiscovery
chembiobryan.bsky.social
Science in the US is primarily funded directly through the departments (NIH, NSF, DOD, etc), philanthropy, and industry. Not sure what you are asking?
chembiobryan.bsky.social
Sure. Private sector also funds science! More science is great!
chembiobryan.bsky.social
Thank you! The main message is aside from the direct health and tech benefits, every dollar invested in science brings ~$2.50 back to the country (across every state!). As far as tax dollars go, that is a great investment. Rest assured we (scientists) take this public trust very seriously.
chembiobryan.bsky.social
Nope! For sure not. See above thread.
chembiobryan.bsky.social
You cannot use grants to pay for dinners! The grant pays for science. Here is some good reading: pmc.ncbi.nlm.nih.gov/articles/PMC... The picture shows a celebration of a group of scientists excited about working hard so our country continues to lead in innovation. That’s good for everyone.
The NIH is a sound investment for the US taxpayer
Research funded by the National Institutes of Health is essential for improving the health of Americans and developing new drugs and treatments for a wide range of diseases. Research organism: None
pmc.ncbi.nlm.nih.gov
chembiobryan.bsky.social
What are you talking about? That’s not how anything works…
chembiobryan.bsky.social
A successful NSF grant in 2025 deserves a nice dinner celebration. Thanks to this incredible crew of rockstars
chembiobryan.bsky.social
Excited to share our most recent work out in @jacs.acspublications.org today! We combined mRNA display with macrocyclic peptide chemistry to discover novel RNA-targeting molecules. This fits into our mission to target RNA regulation with novel therapeutic modalities

pubs.acs.org/doi/10.1021/...
Discovery of Macrocyclic Peptide Binders, Covalent Modifiers, and Degraders of a Structured RNA by mRNA Display
RNA targeting represents a compelling strategy for addressing challenging therapeutic targets that are otherwise intractable through traditional protein targeting. Revolutionary approaches in RNA-focused small molecule libraries have successfully identified RNA-binding ligands but generally remain limited in diversity and impeded by a dearth of structural insight into RNA and RNA complexes. Cyclic peptides are potential structural mimics of evolutionary RNA-protein interacting motifs and can be massively diversified and selected via genetically encoded libraries, offering a complementary approach. This study introduces genetically encoded thioether cyclic peptide libraries constructed through mRNA display using a dibromoxylene linker and its fluorosulfonyl derivative that can covalently engage RNA nucleophiles. Using an optimized mRNA display workflow for RNA binders, we discovered high affinity, covalent and noncovalent binders for SNCA 5′ UTR IRE, the upstream iron-responsive element that post-transcriptionally regulates the expression of α-synuclein, an intrinsically disordered protein implicated in Parkinsonism and related neurodegenerative diseases. Notably, a stringent selection strategy employing “base-paired” target analog counterselection enhanced specificity by deenriching nonspecific electrostatic interactions mediated by polycationic residues. Further engineering hit peptides with an imidazole tag yielded selective RNA degraders in which covalent degraders showed noticeably improved potency from noncovalent counterparts. This work provides a prototype framework for evolution-driven, high-throughput, RNA-targeted drug discovery using cyclic peptides.
pubs.acs.org
Reposted by Bryan Dickinson
blekhman.bsky.social
Update from Chicago. The situation is dire. Complete anarchy. Please send the national guard asap to put an end to this lawlessness
chembiobryan.bsky.social
Congrats to my amazing colleagues John and Dmitri!!! What an inorganic/materials duo powerhouse 💪💪💪.
uchichemistry.bsky.social
Congrats to UChicago Chemistry's Prof Dmitri Talapin, who has been honored with the 2026 ACS Award in Colloid Chemistry, as well as Prof John Anderson, who will receive the 2026 Harry Gray Award for Creative Work in Inorganic Chemistry by a Young Investigator!

chemistry.uchicago.edu/news/uchicag...
UChicago Chemistry Professors Recognized with Prestigious ACS Awards
Dmitri Talapin and John Anderson Honored for Their Pioneering Contributions to Chemistry
chemistry.uchicago.edu
Reposted by Bryan Dickinson
natmethods.nature.com
PANCS-Binders (phage-assisted noncontinuous selection of protein binders) screens multiple high-diversity protein libraries against a panel of dozens of targets for high-throughput binder discovery. @chembiobryan.bsky.social @mstyles-chembiol.bsky.social

www.nature.com/articles/s41...
chembiobryan.bsky.social
We think we can do binder discovery faster and better than anyone in the world - computational or experimental. Happy to be challenged. 2/n
chembiobryan.bsky.social
Thrilled our PANCS-binder tech is finally out in print!
www.nature.com/articles/s41...

This technology, 11-years in the making, has transformed how we do research in my lab, and was led by an amazing postdoc, Matt Styles, who is currently entering the academic job market - so look out for him! 1/n
Reposted by Bryan Dickinson
jenheemstra.bsky.social
First copies of my book are here!! As a new faculty member, I realized that in addition to my research job, I also had a leadership job…and I wasn’t prepared for that.

This book is the guide I wish I’d had then, with the goal of helping others now.
 
jenheemstra.com/book
Picture of a smiling person holding up a copy of a book.
Reposted by Bryan Dickinson
beckchemistry.bsky.social
Our work serves as a crucial reminder to always thoroughly validate your #chemicaltools within each specific experimental context. Assuming specificity, as often happens with FDA for CES2 can lead to misinterpretations. Read the paper at: www.sciencedirect.com/science/arti...
www.sciencedirect.com
Reposted by Bryan Dickinson
whs657257.bsky.social
Check out our interview with winner of 2025 Tetrahedron Young Investigator Award for Bioorganic and Medicinal Chemistry, Professor Bryan Dickinson (@chembiobryan.bsky.social)

www.sciencedirect.com/science/arti...
Interview with the 2025 Tetrahedron Young Investigator Award for Bioorganic and Medicinal Chemistry
www.sciencedirect.com
chembiobryan.bsky.social
So proud of our undergrad Josh Pixley defending his senior thesis @uchicagopme.bsky.social @uchichemistry.bsky.social today. So much energy and passion. I do hope our world capitalizes on the potential of Josh and all the other developing young scientists.
Reposted by Bryan Dickinson
uchichemistry.bsky.social
The UChicago Department of Chemistry is thrilled to welcome Dr. Alex Cusumano to its faculty. His expertise in synthetic organic, organometallic, and computational chemistry will be a valuable asset to our research and educational initiatives. shorturl.at/hqRZK
Dr. Alex Cusumano Joins the University of Chicago Chemistry Department Faculty
New Appointee Brings Expertise in Synthetic, Organometallic, and Computational Chemistry
shorturl.at
Reposted by Bryan Dickinson
wombacherlab.bsky.social
Great to see this work published in the ACS Chemical Biology special issue Lipids and Lipidation, edited by Jeremy Baskin @jeremybaskin.bsky.social and Bryan Dickinson @chembiobryan.bsky.social. (5/5)
Reposted by Bryan Dickinson
uchichemistry.bsky.social
Chemists aren't just in labs; they're building the future of biology. In an introduction to a special issue of Chemical Reviews, Prof Bryan Dickinson describes how chemists are engineering everything from drug-producing microbes to virus-fighting phages. chemistry.uchicago.edu/news/enginee...
Engineering Life's Future with Synthetic Biology
Bryan Dickinson highlights the impact of chemists in synthetic biology in special issue of Chemical Reviews
chemistry.uchicago.edu